Please note that this website is not an official website of Atrium Wake Forest Baptist Health or Wake Forest University School of Medicine. This site was created to inform others about the research activities and work conducted in the Section on Infectious Diseases as part of our wider social media presence.
Dr Tom Wierzba is a professor of infectious diseases at Wake Forest University School of Medicine. His research focuses on the epidemiology and control of enteric pathogens, particularly those that are responsible for diarrhea and other gastrointestinal illnesses. He is also interested in the development of new vaccines and other interventions to prevent and treat these diseases.
Prior to joining Wake Forest University School of Medicine, was a senior scientist at PATH, the director general of the International Vaccine Institute, and served in a variety of roles around the world as a member of the U.S. Centers for Disease Control and Prevention including Bangladesh, Uganda, and Egypt. He is also a member of Blue Collar Vaccines and Theraputics, start up composed of a team of infectious disease experts and engineers.
Recent publications
Automatic case cluster detection using hospital electronic health record data.
Could a Shigella vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021.
Bagamian KH, Puett C, Anderson JD 4th, Muhib F, Pecenka C, Behrman J, Breiman RF, Edoka I, Horton S, Kang G, Kotloff KL, Lanata CF, Platts-Mills JA, Qadri F, Rogawski McQuade ET, Sudfeld C, Vonaesch P, Wierzba TF, Scheele S
Journal: Vaccine: X · Publish Date: 2022 Dec · DOI: 10.1016/j.jvacx.2022.100218 · PMID: 36237199
Vaccine-induced seroconversion in participants in the North Carolina COVID-19 community Research Partnership.
Friedman-Klabanoff DJ, Tjaden AH, Santacatterina M, Munawar I, Sanders JW, Herrington DM, Wierzba TF, Berry AA, COVID-19 Community Research Partnership
Survey of Adherence with COVID-19 Prevention Behaviors During the 2020 Thanksgiving and Winter Holidays Among Members of the COVID-19 Community Research Partnership.
Peacock JE Jr, Herrington DM, Edelstein SL, Seals AL, Plumb ID, Saydah S, Lagarde WH, Runyon MS, Maguire PD, Correa A, Weintraub WS, Wierzba TF, Sanders JW, COVID-19 Community Research Partnership Study Group
Journal: Journal of community health · Publish Date: 2022 Feb · DOI: 10.1007/s10900-021-01021-z · PMID: 34383157
Analysis of accumulated SARS-CoV-2 seroconversion in North Carolina: The COVID-19 Community Research Partnership.
Williamson JC, Wierzba TF, Santacatterina M, Munawar I, Seals AL, Pittman Ballard CA, Alexander-Miller M, Runyon MS, McCurdy LH, Gibbs MA, Ahmed A, Lagarde WH, Maguire PD, King-Thiele R, Hamrick T, Ihmeidan A, Henderson S, Gallaher TR, Uschner D, Edelstein SL, Herrington DM, Sanders JW, North Carolina sites of the COVID-19 Community Research Partnership
